CLINICAL_TRIALS
trial_result
· 2018-10-31
Clinical Trial Update: Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib [Phase 1]
Summary
Phase 1 pharmacokinetics and metabolism study of alisertib completed; reports mass balance data in advanced solid tumors and lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Solid Tumors, Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2018-10-31